Penumbra, Inc.

PENNYSEUSD
324.37 USD
0.62 (0.19%)🔴AT CLOSE (AS OF 08:06 PM EDT)
🔴Market: CLOSED

Shares of Penumbra, Inc. (PEN) are trading at $324.37. The stock presents a bullish profile across the board: both technical indicators and our fundamental models signal a "Buy" and "Buy" respectively. Key drivers include a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. Furthermore, PEN is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Aug 25, 2026.

Open?$323.70
High?$324.86
Low?$323.32
Prev. Close?$323.75
Volume?271.6K
Avg. Volume?336.2K
VWAP?$324.42
Rel. Volume?0.81x
Bid / Ask
Bid?$314.50 × 40
Ask?$345.00 × 40
Spread?$30.50
Midpoint?$329.75
Valuation & Ratios
Market Cap?12.8B
Shares Out?39.4M
Float?38.2M
Float %?97.1%
P/E Ratio?79.41
P/B Ratio?8.33
EPS?$4.08
Dividend?0.00%
Ex-Dividend?N/A
RelatedLNTHITGR
News
Profile
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Employees
4.7K
Market Cap
12.8B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2015-09-18
Address
ONE PENUMBRA PLACE
ALAMEDA, CA 94502
Phone: (510) 995-2486
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
100
Momentum?
75
Short Sent.?
42
Piotroski F-Score?5/9Mixed
Altman Z-Score?19.20Safe
Confidence?67%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?4.76%Low
Short Interest?1.8M
Days to Cover?7.0
Free Float38.2M
Avg Daily Volume260.3K
Settlement Date2026-08-14
Financial Health
Current Ratio?5.75Strong
Quick Ratio?3.86Strong
Cash Ratio?0.88Adequate
Debt/Equity?0.01Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
33/100
P/E?
Peers
33
S&P
3
79.4PRICEY
P/B?
Peers
33
S&P
23
8.33HIGH
P/S?
Peers
33
S&P
11
8.47HIGH
P/FCF?
Peers
33
S&P
8
59.1PRICEY
EV/EBITDA?
Peers
33
S&P
3
61.5HIGH
EV/Sales?
Peers
33
S&P
16
8.35HIGH
Returns & Efficiency
ROE?
Peers
67
S&P
37
10.5%FAIR
ROA?
Peers
67
S&P
66
8.1%STRONG
Cash Flow & Enterprise
FCF?$215.9M
Enterprise Value?$12.6B
Fundamentals ratios updated end of day